Yahoo
NSE - Delayed Quote INR

Emcure Pharmaceuticals Limited (EMCURE.NS)

1,883.50 +11.70 (+0.63%)
At close: 3:29:52 PM GMT+5:30
EMCURE.NS Q2 2027 earnings call
November 3, 2026 at 4:00 PM GMT+5:30
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Assets
96,124,810
82,327,230
78,061,630
66,725,310
Total Liabilities Net Minority Interest
46,358,080
35,911,690
46,843,980
40,228,710
Total Equity Gross Minority Interest
49,766,730
46,415,540
31,217,650
26,496,600
Total Capitalization
52,022,430
46,361,230
37,188,780
32,452,610
Common Stock Equity
49,500,320
44,461,860
29,522,830
25,011,260
Capital Lease Obligations
3,171,580
2,910,450
2,476,600
1,393,700
Net Tangible Assets
38,489,320
34,991,770
20,658,290
21,575,780
Working Capital
16,998,620
18,875,930
10,494,420
8,167,200
Invested Capital
61,541,150
51,778,900
50,395,940
46,960,600
Tangible Book Value
38,489,320
34,991,770
20,658,290
21,575,780
Total Debt
15,212,410
10,227,490
23,349,710
23,343,040
Net Debt
11,008,790
6,098,800
19,783,540
21,385,680
Share Issued
189,589.55
189,483.35
189,098.35
189,098.35
Ordinary Shares Number
189,589.55
189,483.35
189,098.35
189,098.35
Treasury Shares Number
0
--
--
--
3/31/2023 - 7/10/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: